THE ROLE OF GENETIC POLYMORPHISM OF THE FILAGGRIN PROTEIN WITH ATOPIC MARCH PROGRESSION IN CHILDREN
PDF

Як цитувати

Stoieva, T., Reshetilo, O., Vesilyk, N., Portnova, O., Fedin, M., & Larionov, O. (2021). THE ROLE OF GENETIC POLYMORPHISM OF THE FILAGGRIN PROTEIN WITH ATOPIC MARCH PROGRESSION IN CHILDREN. InterConf, (58), 187-200. https://doi.org/10.51582/interconf.21-22.05.2021.022

Анотація

The aim of the study. To determine the role of genetic polymorphism in the filaggrin gene R501XAA and 2282de4AA at atopic march progression in children. Materials and methods. 111 children aged 3 to 12 years with atopic dermatitis were selected and examined. As a result of genetic testing, it was found that 51 children with atopic dermatitis had polymorphism in the filaggrin gene. These patients were included in the main group. Another 60 children without polymorphism were in the control group. The filaggrin gene polymorphism was determined by examining the buccal epithelium by Dellaporta method. Sensitization to allergens was established on the basis of the specific IgE level. The impact of the disease on the quality of life of children was performed using the CDLQI questionnaire (Children's Dermatology Life Quality Index). Results. In the course of molecular genetics research, R501X mutation was detected in 40 ((78.4 ± 5.76)%) children, 2282del4 polymorphism – in 4 ((7.8 ± 3.76)%) patients, and their combined variant R501X + 2282del4 – in 7 (13%), (7 ± 4.81)% patients. When determining the effect of filaggrin polymorphism on the clinical course of atopic dermatitis, the presence of the associative relationship was established with the following indicators: the early onset of the disease – χ2 = 33.2, mostly severe course – χ2 = 16.2, severe skin dryness – χ2 = 22.6, predominant sensitization to fungi – χ2 = 10.6 and house dust mites – χ2 = 12.2, violation of the skin microbiome – χ2 = 7.8. Conclusions. Early manifestation of atopic dermatitis in children is associated with the filaggrin protein gene polymorphism ((82.4 ± 5.33)%), which determines the risk of progression of the atopic march and the development of bronchial asthma in (38.0 ± 6.8)% of children.

https://doi.org/10.51582/interconf.21-22.05.2021.022
PDF

Посилання

Mechanisms of the development of allergy (MeDALL): introducing novel concepts in allergy pheno types / J. M. Anto, J. Bousquet, M. Akdis [et al.] // J. Allergy Clin. Immunol. – 2017. – Vol. 139 (2). – P. 388–399.

Kabesch M. Recent findings in the genetics and epigenetics of asthma and allergy / M. Kabesch, J. Tost // Semin. Immunopathol. – 2020. – Vol. 42 (1). – P. 43–60.

Levin J. Atopic Dermatitis and the stratum corneum. Part 2: Other structural and functional characteristics of the stratum corneum barrier in atopic skin / J. Levin, S. F. Friedlander, J. Q. Del Rosso // J. Clin. Aesthetet Dermatol. – 2013. – Vol. 6 (11). – P. 49–54.

Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort / N. Ballardini, I. Kull, C. Soderhall [et al.] // Br. J. Dermatol. – 2013. – V. – Vol. 51 (3). – P. 315–328.

Portelli M. A. Genetic risk factors for the develool. 168 (3). – P. 588–594.

Liang Y. The genetics and epigenetics of atopic dermatitis–filaggrin and other polymorphisms / Y. Liang, C. Chang, Q. Lu // Clin. Rev. Allergy Immunol. – 2016pment of allergic disease identified by genome–wide association / M. A. Portelli, E. Hodge, I. Sayers // Clin. Exp. Allergy. – 2015. – Vol. 45 (1). – P. 21–31.

McAleer M. A. The multifunctional role of filaggrin in allergic skin disease / M. A. McAleer, A. D. Irvine // J. Allergy Clin. Immunol. – 2013. – Vol. 131 (2). – P. 280–291.

Атопический дерматит у детей: современные клинические рекомендации по диагностике и терапии / Л. С. Намазова-Баранова, А. А. Баранов, А. А. Кубанова [и др.] //Вопросы современной педиатрии. – 2016;15(3):279-294.

Волосовец А. П. Роль филлагрина в аллергологии детского возраста / А. П. Волосовец, С. П. Кривопустов, Е. В. Павлик // Здоровье ребенка. – 2013. – № 2. – С. 12–15.

Lodén M. Treatments improving skin barrier function / M. Lodén // Curr. Probl. Dermatol. – 2016. – Vol. 49. – P. 112–122. 11. Беш Л. В. Атопічні дерматити у дітей: аналіз діагностичних і тактичних помилок / Л. В. Беш // Здоров᾽я України. – 2013. – С. 52–53.

Mutations in the gene filaggrin in patients with atopic dermatitis as a risk factor for the severity of the disease / I. I. Balabolkin, I. A. Larkova, V. A. Bulgakova [et al.] // Allergy. – 2016. – Vol. 71 (S102). – P. 300–301.

Калюжная Л. Д. Разнообразие топической терапии атопического дерматита как фактор преодоления кортикофобии / Л. Д. Калюжная // Клиническая иммунология. Алергология. Инфектология. – 2014. – № 8 (77). – С. 19–23.

Atopic eczema and fracture risk in adults: A population–based cohort study / K. E. Lowe, J. Zein, U. Hatipoglu, A. Attaway // J. Allergy Clin. Immunol. – 2020. – Vol. 145 (2). – P. 563–571.

Dennin M. Filaggrin and childhood eczema / M. Dennin, P. A. Lio // Arch. Dis. Child. – 2017. – Vol. 102 (12). – P. 1101–1102.

Kim K. H. Overview of atopic dermatitis / K. H. Kim // Asia Pac. Allergy. – 2013. – Vol. 3 (2). – Р. 79–87.

Association between P478S polymorphism of the filaggrin gene & atopic dermatitis / S.–Y. Kim, S. W. Yang, H.–L. Kim [et al.] // Indian J. Med. Res. – 2013. – Vol. 138 (6). – P. 922–927.

Зуева М. И. Мутации R501X и 2282del4 гена FLG у больных аллергодерматозами/ М. И. Зуева //Вісник Харківського національного університету імені В. Н. Каразіна. Серія : Біологія. – 2011. – № 947, Вип. 13. – С. 93–97. – Режим доступу: http://nbuv.gov.ua/UJRN/VKhb_2011_947_13_16.

Дитятковський В. О. Атопічний марш у педіатрії: генотип-асоційовані механізми. Частина 1. Генотип-асоційовані механізми хвороб атопічного маршу в дітей/ В. О. Дитятковський //Здоров'я дитини. – 2017. – Т. 12, № 4. – С. 498–504. – Режим доступу: http://nbuv.gov.ua/UJRN/Zd_2017_12_4_14 DOI: 10.22141/2224-0551.12.4.2017.107632.

Функціональне значення однонуклеотидного поліморфізму (rs11204981) в гені філаггріну (FLG) для лікування бронхіальної астми у дітей з атопічним дерматитом / О. П. Волосовець, В. Є. Досенко, С. П. Кривопустов [та ін.] // Здоровье ребёнка. – 2015. – № 1 (60). – С. 14–18.

Correlation of age-of-onset of atopic dermatitis with filaggrin loss-of-function variant status / S. P. Smieszek, S. Welsh, C. Xiao [et al.] // Sci. Rep. – 2020. – Vol. 10 (1). – P. 2721.

Anto, J.M., Bousquet, J., Akdis, M., Auffray, C., Keil, T., Momas, I., & Xu, C.J. (2017). Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy pheno types. J. Allergy Clin. Immunol., 139 (2), 388-399. DOI: 10.1016/j.jaci.2016.12.940

Kabesch, M., & Tost, J. (2020). Recent findings in the genetics and epigenetics of asthma and allergy. Semin. Immunopathol., 42 (1), 43-60. DOI: 10.1007/s00281- 019-00777-w.

Levin, J., Friedlander, S.F., & Del Rosso, J.Q. (2013). Atopic dermatitis and the stratum corneum. Part 2: Other structural and functional characteristics of the stratum corneum barrier in atopic skin. J. Clin. Aesthet. Dermatol., 6 (11), 49-54.

Ballardini, N., Kull, I., Söderhäll, C., Lilja, G., Wickman, M., & Wahlgren, C.F. (2013). Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br. J. Dermatol., 168 (3), 588-594. DOI: 10.1111/bjd.12196.

Liang, Y., Chang, C., & Lu, Q. (2016). The genetics and epigenetics of atopic dermatitis–filaggrin and other polymorphisms. Clin. Rev. Allergy Immunol., 51 (3), 315-328. DOI: 10.1007/s12016-015-8508-5.

Portelli, M.A., Hodge, E., & Sayers, I. (2015). Genetic risk factors for the development of allergic disease identified by genome–wide association. Clin. Exp. Allergy, 45 (1), 21-31. DOI: 10.1111/cea.12327.

McAleer, M.A., & Irvine, A.D. (2013). The multifunctional role of filaggrin in allergic skin disease. J. Allergy Clin. Immunol., 131 (2), 280-291. DOI: 10.1016/j.jaci.2012.12.668.

Namazova-Baranova, L.S., Baranov, A.A., Kubanova, A.A., Ilina, N.I., Kurbacheva, O.M., Vishneva, E.A., ..., & Voznesenskaya, N.I. (2016). Atopic dermatitis in children: current clinical guidelines for diagnosis and therapy. Curr. Pediatrics, 15 (3), 279-294. DOI: https://doi.org/10.15690/vsp.v15i3.1566.

Volosovets, A.P., Krivopustov, S.P., & Pavlik, Ye.V. (2013). Rol fillagrina v allergologii detskogo vozrasta [The role of phillagrin in allergology of children]. Zdorovye rebenka – Child Health, 2, 12-15 [in Russian].

Lodén, M. (2016). Treatments improving skin barrier function. Curr. Probl. Dermatol., 49, 112-122. DOI: 10.1159/000441586.

Besh, L.V. (2013). Atopichni dermatyty u ditei: analiz diahnostychnykh i taktychnykh pomylok [Atopic dermatitis in children: analysis of diagnostic and tactical errors]. Zdorovia Ukrainy – Health of Ukraine, 52-53 [in Ukrainian].

Balabolkin, I.I., Larkova, I.A., Bulgakova, V.A., Pinelis, V.G., Gusar, V.A., & Janin, I.S. (2016). Mutations in the gene filaggrin in patients with atopic dermatitis as a risk factor for the severity of the disease. Allergy, 71 (S102), 300-301. Retrieved from: https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.12974.

Kalyuzhnaya, L.D. (2014). Raznoobraziye topicheskoy terapii atopicheskogo dermatita kak faktor preodoleniya kortikofobii [Variety of topical therapy for atopic dermatitis as a factor in overcoming corticophobia]. Klinichna imunologiya. Alergologiya. Infektologiya – Clinical immunology. Allergology. Infectology, 8 (77), 19-23 [in Russian].

Lowe, K.E., Zein, J., Hatipoglu, U., & Attaway, A. (2020). Atopic eczema and fracture risk in adults: A population–based cohort study. J. Allergy Clin. Immunol., 145 (2), 563-571. DOI: 10.1016/j.jaci.2019.09.015.

Dennin, M., & Lio, P.A. (2017). Filaggrin and childhood eczema. Arch. Dis. Child., 102 (12), 1101-1102. DOI: 10.1136/archdischild–2017–313010.

Kim, K.H. (2013). Overview of atopic dermatitis. Asia Pac. Allergy, 3 (2), 79-87. DOI: https://doi.org/10.5415/apallergy.2013.3.2.79.

Kim, S.Y., Yang, S.W., Kim, H.L., Kim, S.H., Kim, S.J., Park, S.M., & Um, J.Y. (2013). Association between P478S polymorphism of the filaggrin gene & atopic dermatitis. Indian J. Med. Res., 138 (6), 922-927.

Zuyeva, M.I. (2011). Mutatsii R501X i 2282del4 gena FLG u bolnykh allergodermatozami [R501X and 2282del4 mutations of FLG gene in allergodermatoses patients]. Visnyk Kharkivskoho natsionalnoho universytetu imeni V. N. Karazina. Seriya: Biolohiya – Bulletin of V.N. Karazin Kharkiv National University. Series: Biology, 13 (947), 93-97. Retrieved from: http://nbuv.gov.ua/UJRN/VKhb_2011_947_13_16 [in Russian].

Dytiatkovskyi, V.O. (2017). Atopichnyi marsh u pediatrii: henotyp-asotsiiovani mekhanizmy. Chastyna 1. Henotyp-asotsiiovani mekhanizmy khvorob atopichnoho marshu v ditei [Atopic march in pediatrics: genotype-associated mechanisms. Part 1. Genotype-associated mechanisms of the atopic march in children]. Zdorovia dytyny – Child Health, 12 (4), 498-504. Retrieved from: http://nbuv.gov.ua/UJRN/Zd_2017_12_4_14. DOI: 10.22141/2224-0551.12.4.2017.107632 [in Ukrainian].

Volosovets, O.P., Dosenko, V.Ye., Kryvopustov, S.P., Pavlyk, O.V., Yemets, O.V., & Stroi, D.O. (2015). Funktsionalne znachennia odnonukleotydnoho polimorfizmu (rs11204981) v heni filahhrinu (FLG) dlia likuvannia bronkhialnoi astmy u ditei z atopichnym dermatytom [Functional significance of single-nucleotide polymorphism (rs11204981) in filaggrin (FLG) gene for the treatment of bronchial asthma in children with atopic dermatitis]. Zdorovye rebenka – Child Health, 1 (60), 14-18 [in Ukrainian].

Smieszek, S.P., Welsh, S., Xiao, C., Wang, J., Polymeropoulos, C., Birznieks, G., & Polymeropoulos, M.H. (2020). Correlation of age-of-onset of atopic dermatitis with filaggrin loss-of-function variant status. Sci. Rep., 10 (1), 2721. DOI: 10.1038/s41598-020-59627-7.

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.

Завантаження

Дані завантаження ще не доступні.

| Переглядів: 16 | Завантажень: 13 |